Dispensations of tirzepatide and semaglutide increased significantly in recent years while the use of other glucose-lowering ...

Discover Mounjaro Tirzepatide's impact on obesity in India post its March launch. Get insights on effectiveness against ...

If you're starting a semaglutide GLP-1 RA medication like Wegovy or Ozempic for weight loss, you may be wondering how soon ...

Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...

Certain foods can worsen GI side effects from GLP-1 durgs. Learn which foods to avoid and which to choose instead.

XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic benefits through a unique fat-blocking mechanism. However, its high ...

Novo Nordisk’s Vikrant Shrotriya on accelerating Wegovy’s launch, pricing strategy, and building long-term obesity care ...

No. The recommended starting dose for Wegovy is 0.25 milligrams (mg). You’ll need to take 0.25 mg once per week for the first 4 weeks of treatment. Starting at this dosage reduces the risk of ...

Backed by the global SELECT (Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity) trial, semaglutide 2.4 mg (the active ingredient in Wegovy) was associated with a ...

Novo Nordisk is preparing to launch its blockbuster obesity drug Wegovy (injectable semaglutide) in India later this year, ...

Currently, only liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound) are approved for weight loss, though some other GLP-1 drugs may be prescribed off-label. Keep in mind that ...

Wall Street went on a $2.4 trillion joyride Monday— all because of a rogue tweet claiming that President Donald Trump might pause his punishing new tariffs for 90 days. The massive swing ...